Showing results (301-310 of 4,371) with videos related to

Sort By:
Pageof 438
Obstetrics and Gynecology|October 1, 1994
Safety of the new quinolones in pregnancyM Berkovitch, A Pastuszak, M Gazarian, et al.
Journal of Clinical Pharmacology|June 27, 2000
Drug labeling and risk perceptions of teratogenicity: a survey of pregnant Canadian women and their health professionalsM Pole, A Einarson, N Pairaudeau, et al.
Canadian Journal of Physiology and Pharmacology|January 5, 2002
The role of the placenta in variability of fetal exposure to cocaine and cannabinoids: a twin studyR Boskovic, J Klein, C Woodland, et al.
Canadian Family Physician Medecin De Famille Canadien|June 26, 2001
Congenital cytomegalovirus infection. Is there a breakthrough?B Bar-Oz, M Berkovitch, L Ford-Jones, et al.
Canadian Family Physician Medecin De Famille Canadien|February 7, 2001
Can we use anxiolytics during pregnancy without anxiety?A Addis, L R Dolovich, T R Einarson, et al.
Clinical Pharmacology and Therapeutics|May 13, 2011
The human placental perfusion model: a systematic review and development of a model to predict in vivo transfer of therapeutic drugsJ R Hutson, F Garcia-Bournissen, A Davis, et al.
American Journal of Obstetrics and Gynecology|March 1, 1990
Maternal spermicide use and adverse reproductive outcome: a meta-analysisT R Einarson, G Koren, D Mattice, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|August 1, 1996
Nicotine and cotinine in maternal and neonatal hair as markers of gestational smokingC Eliopoulos, J Klein, D Chitayat, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1991
Pregnancy-induced changes in drug metabolism in epileptic womenM Bologa, B Tang, J Klein, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1987
Vancomycin pharmacokinetics and dose recommendations for preterm infantsA James, G Koren, J Milliken, et al.
Pageof 438